Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Corporate Action | 10 February 2026

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Apollo Hospitals reported strong Q3 FY26 consolidated revenue of ₹6,477 crore (17% YoY growth) and PAT of ₹502 crore (35% YoY growth). Nine-month revenue reached ₹18,623 crore (15% YoY growth) with PAT of ₹1,412 crore (34% YoY growth). The Board approved a ₹10 per share interim dividend (200% of face value, record date February 16, 2026). A major corporate restructuring involves demerging pharmacy distribution and digital health businesses into Apollo Healthtech Limited, pending NCLT approval.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day